ArticleThe oncologist2026

Radiographic progression-free survival as a surrogate endpoint for overall survival in first-line ARPi naïve metastatic castration-resistant prostate cancer.

Elena Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.